• Sisomicin and Tobramycin: Comparative In Vitro Activity Insi

  2026-06-22

  The reference study systematically evaluated the in vitro antibacterial activity of sisomicin, a novel aminoglycoside, compared with established antibiotics including tobramycin and gentamicin. The findings clarify the relative potencies of these agents against clinical Gram-negative and Gram-positive isolates, informing antibiotic selection and resistance research.

• 2'3'-cGAMP (Sodium Salt): Precision Delivery Fuels Next-Gen

  2026-06-22

  Explore the transformative impact of 2'3'-cGAMP (sodium salt) in advancing STING-mediated innate immune research. This article uniquely dissects nanoparticle delivery innovations, practical assay implications, and deeper translational challenges for immunotherapy.

• MOF-Based mRNA Encapsulation: Advancements in Non-Viral Deli

  2026-06-21

  The referenced study introduces a synthetic strategy for encapsulating mRNA within zeolitic imidazole framework-8 (ZIF-8) metal-organic frameworks, enhanced by polyethyleneimine for improved stability and delivery. This approach demonstrates prolonged mRNA retention, efficient cellular uptake, and successful protein expression, offering a promising new avenue for non-viral gene delivery system development.

• In Situ Tracking of Endogenous Proteins with Allosteric Bios

  2026-06-20

  This study introduces a genetically encoded, allosteric biosensor system—circStep—for live-cell, high-fidelity visualization of native protein dynamics. The approach overcomes the limitations of exogenous overexpression and genome editing, enabling accurate spatiotemporal tracking of endogenous proteins while minimizing artifacts and preserving physiological relevance.

• JC-1 Mitochondrial Membrane Potential Assay Kit in Next-Gen

  2026-06-19

  Explore how the JC-1 Mitochondrial Membrane Potential Assay Kit enables advanced mitochondrial function analysis and empowers immunomodulatory research by integrating mechanistic insights and translational applications. Discover unique assay decision points grounded in cutting-edge evidence.

• V5 Epitope Tag Peptide: Applied Workflows and Advanced Detec

  2026-06-19

  The V5 Epitope Tag Peptide streamlines protein detection, purification, and advanced imaging, offering unmatched specificity and solubility for recombinant protein analysis. Learn how its integration with next-generation antibody screening and super-resolution microscopy unlocks new experimental insights and reproducibility.

• VEGFC–Macrophage Axis in NASH: Evidence from Inhibition Stud

  2026-06-18

  This study demonstrates that targeting VEGFC signaling in hepatocytes disrupts macrophage-driven fibrosis in a mouse model of NASH. Both naringin and selective VEGFR-3 inhibition (SAR131675) ameliorate hepatic inflammation and fibrotic progression, highlighting VEGFC–macrophage crosstalk as a promising research target.

• Applied Workflows with SB 431542: ALK5 Inhibitor in TGF-β Re

  2026-06-18

  SB 431542 stands as a benchmark ALK5 inhibitor for dissecting the TGF-β pathway, enabling precise modulation of Smad2/3 signaling in cancer, fibrosis, and immunology models. This article delivers actionable protocols, troubleshooting strategies, and research-driven insights, translating the latest mechanistic findings into practical bench applications.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-06-17

  A recent study reveals that naturally occurring angiotensin fragments, including Angiotensin 1/2 (1-6), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings establish a mechanistic bridge between renin-angiotensin system peptides and viral entry, with implications for both cardiovascular and infectious disease research.

• Luminescent ATP Detection Assay Kit: Precision in Glioblasto

  2026-06-17

  The Luminescent ATP Detection Assay Kit leverages firefly luciferase for ultrasensitive ATP quantification, streamlining metabolic research in cells and tissues. Its robust linearity and sample compatibility empower energy metabolism studies, including those dissecting glycolytic drivers in glioblastoma.

• EGCG Nanoparticles Enhance FLASH-RT Antitumor Efficacy via D

  2026-06-16

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly sensitize tumors to ultra-high dose rate radiotherapy (FLASH-RT) by amplifying DNA damage and orchestrating a favorable immune response. The findings suggest new avenues for improving cancer radiotherapy efficacy and immune modulation.

• Machine Learning Accelerates Discovery of Novel Senolytics

  2026-06-16

  This paper introduces a data-driven approach leveraging machine learning to identify new senolytic compounds, substantially reducing the cost and scale of traditional drug screening. The findings provide actionable insights for researchers targeting cellular senescence in cancer and aging.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow

  2026-06-15

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody provides robust detection and signal amplification for rabbit primary antibodies in immunoassays such as ELISA, Western blot, IHC, and IC. This reagent is not intended for diagnostic or clinical applications and should be avoided in workflows requiring monoclonal or subclass-specific detection.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in Vascular

  2026-06-15

  Angiotensin II (SKU A1042) is an essential tool for modeling hypertension mechanisms, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy in cellular and animal research. It provides defined, reproducible activation of angiotensin receptors and downstream signaling. Researchers should avoid extrapolating its use to diagnostic or clinical applications and adhere closely to recommended protocols for optimal results.

• Imatinib Hydrochloride: Optimized Protocols for Cancer Resea

  2026-06-14

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor, enabling precise inhibition of v-Abl, c-Kit, and PDGFR signaling in advanced cancer models. Explore optimized workflows, troubleshooting guidance, and the latest mechanistic insights that empower robust chronic myelogenous leukemia and gastrointestinal stromal tumor research using APExBIO’s high-quality compound.

15681 records 1/1046 page Next 12345 下5页 Last page